Short-term administration of granulocyte-macrophage colony stimulating factor decreases hematopoietic toxicity of cytostatic drugs

This publication has 17 references indexed in Scilit:

• Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level.
  Journal of Clinical Oncology, 1992
• In vivo effect of human granulocyte-macrophage colony-stimulating factor on megakaryocytopoiesis
  Blood, 1991
• In vivo priming of human normal neutrophils by granulocyte‐macrophage colony stimulating factor: effect on the production of platelet activating factor
  British Journal of Haematology, 1990
• Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer
  British Journal of Cancer, 1990
• Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer.
  Journal of Clinical Oncology, 1989
• Clinical Use of Recombinant Human Hematopoietic Growth Factors
  JNCI Journal of the National Cancer Institute, 1989
• The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells
  Nature, 1989
• Kinetics of human hemopoietic cells after in vivo administration of granulocyte-macrophage colony-stimulating factor.
  Journal of Clinical Investigation, 1989
• Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced Myelosuppression
  New England Journal of Medicine, 1988
• Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency Syndrome
  New England Journal of Medicine, 1987